6-Butyl-2-(2,4-difluorophenyl)-1,3,6,2-dioxazaborocane

Catalog No.: 
ACOZKX804
CAS No.: 
1190988-98-7
Molecular Formula: 
C14H20BF2NO2
Molecular Weight: 
283.13
6-Butyl-2-(2,4-difluorophenyl)-1,3,6,2-dioxazaborocane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$236.00InquiryInquiry
250mg95%$451.00InquiryInquiry
1g95%$894.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Butyl-2-(2,4-difluorophenyl)-1,3,6,2-dioxazaborocane
IUPAC Name6-butyl-2-(2,4-difluorophenyl)-1,3,6,2-dioxazaborocane
MDL No.MFCD28400570
Molecular FormulaC14H20BF2NO2
Molecular Weight283.13
SMILESFC1=CC=C(B2OCCN(CCCC)CCO2)C(F)=C1
InChI KeyTVKNBFFXRJYTMU-UHFFFAOYSA-N
Synonym6-butyl-2-(2,4-difluorophenyl)-1,3,6,2-dioxazaborocane
CAS No.1190988-98-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOZKX804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZKX804 route product structure diagram
    ACOZKX8041190988-98-7
Inquiry

2. ACOZKX804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOZKX804 route product structure diagram
    ACOZKX8041190988-98-7
Inquiry

3. ACOZKX804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZKX804 route product structure diagram
    ACOZKX8041190988-98-7
Inquiry

Comments (0)